期刊
JOURNAL OF LEUKOCYTE BIOLOGY
卷 89, 期 1, 页码 127-136出版社
WILEY
DOI: 10.1189/jlb.1009696
关键词
dendritic cells; CD26; T cell activation; Th1; CD45RA/CD45RO; Foxp3
资金
- FIPSE [36750/08, 36536/05]
- Spanish Ministry of Health [36750/08, 36536/05]
- Abbott Laboratories [36750/08, 36536/05]
- Boehringer Ingelheim [36750/08, 36536/05]
- Bristol Myers Squibb [36750/08, 36536/05]
- GlaxoSmithKline [36750/08, 36536/05]
- Merck Sharp [36750/08, 36536/05]
- Dohme and Roche [36750/08, 36536/05]
- HIVACAT (Center for Research and Development of HIV Vaccines in Catalonia)
- ISCIII-RETIC [RD06/006]
- FONDECYT [1095114]
- Comision Nacional de Investigacion Cientifica y Tecnologica [PFB-16]
- [FIS-PI06-1259]
- [RIS-173]
- [USS-5048]
By interacting with CD26 on the CD4(+) T cell surface and with the AdoR A(2B) on the DC surface, ADA triggers a costimulatory signal for human T cells. The aim of this study was to know whether ADA-mediated costimulation plays a role in the differentiation of T cells. The results show that irrespective of its enzymatic activity and dependent on TNF-alpha, IFN-gamma, and IL-6 action, ADA enhanced the differentiation of CD4(+)CD45RA(+)CD45RO(-) naive T cells toward CD4(+)CD25(+)CD45RO(+) Teffs and CD4(+)CD45RA(-)CD45RO(+) memory T cells. Furthermore, ADA potentiated generation of CD4(+)CD25(high)Foxp3(+) Tregs by a mechanism that seems to be mainly dependent on the enzymatic activity of ADA. Interestingly, an ADA-mediated increase on Teff, memory T cell, and Treg generation occurred, not only in cocultures from healthy individuals but also from HIV-infected patients. These data suggest that ADA is a relevant modulator of CD4(+) T cell differentiation, even in cells from immuno-logically compromised individuals. J. Leukoc. Biol. 89: 127-136; 2011.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据